Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eunice L Kwak

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Clinical Colorectal Cancer|February 22, 2007
Hereditary colorectal cancer syndromes: an overviewEunice L Kwak, Daniel C Chung
Annals of Surgical Oncology|May 21, 2014
Adjuvant therapy for gastric cancers: more answers or more questions?Theodore S Hong, Eunice L Kwak
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Targeted agents: the rules of combinationEunice L Kwak, Jeffrey W Clark, Bruce Chabner
Seminars in Radiation Oncology|December 5, 2012
Targeted therapies with chemoradiation in esophageal cancer: development and future directionsTheodore S Hong, Jennifer Y Wo, Eunice L Kwak
Annals of Surgical Oncology|July 28, 2016
What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric CancerJohn T Mullen, Eunice L Kwak, Theodore S Hong
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeted inhibition in tumors with ALK dependencyEunice L Kwak, Jeffrey W Clark, Alice T Shaw
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A matter of timing: is there a role for radiation in locally advanced pancreatic cancer, and if so, when?Theodore S Hong, Jennifer Y Wo, Eunice L Kwak
The New England Journal of Medicine|December 14, 2016
Case 35-2016. A 62-Year-Old Man with DysphagiaEunice L Kwak, Theodore S Hong, David G Forcione, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2015
Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic diseaseEmily Chan, Eunice L Kwak, Jimmy Hwang, et al.
Cancer Research|February 21, 2006
Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutantEunice L Kwak, Sang Kim, Jianmin Zhang, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Clinical Colorectal Cancer|February 22, 2007
Hereditary colorectal cancer syndromes: an overviewEunice L Kwak, Daniel C Chung
Annals of Surgical Oncology|May 21, 2014
Adjuvant therapy for gastric cancers: more answers or more questions?Theodore S Hong, Eunice L Kwak
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Targeted agents: the rules of combinationEunice L Kwak, Jeffrey W Clark, Bruce Chabner
Seminars in Radiation Oncology|December 5, 2012
Targeted therapies with chemoradiation in esophageal cancer: development and future directionsTheodore S Hong, Jennifer Y Wo, Eunice L Kwak
Annals of Surgical Oncology|July 28, 2016
What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric CancerJohn T Mullen, Eunice L Kwak, Theodore S Hong
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Targeted inhibition in tumors with ALK dependencyEunice L Kwak, Jeffrey W Clark, Alice T Shaw
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
A matter of timing: is there a role for radiation in locally advanced pancreatic cancer, and if so, when?Theodore S Hong, Jennifer Y Wo, Eunice L Kwak
The New England Journal of Medicine|December 14, 2016
Case 35-2016. A 62-Year-Old Man with DysphagiaEunice L Kwak, Theodore S Hong, David G Forcione, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2015
Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic diseaseEmily Chan, Eunice L Kwak, Jimmy Hwang, et al.
Cancer Research|February 21, 2006
Mammary tumorigenesis following transgenic expression of a dominant negative CHK2 mutantEunice L Kwak, Sang Kim, Jianmin Zhang, et al.
Pageof 9